⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL13836101 | 0.91 | TSHR (0.42) | — | |
| SCHEMBL28144105 | 0.74 | — | — | |
| SCHEMBL8325250 | 0.74 | LMNA (0.39) | — | |
| SCHEMBL18893110 | 0.70 | — | — | |
| SCHEMBL45688 | 0.70 | — | — | |
| SCHEMBL14688702 | 0.70 | — | — | |
| SCHEMBL5934990 | 0.70 | — | — | |
| SCHEMBL31275910 | 0.70 | — | — | |
| SCHEMBL5596926 | 0.70 | — | — | |
| SCHEMBL16938847 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113004511-A | Stable modified polymer polyol dispersions | 雷普索尔有限公司 | 2021-06-22 | — | — | CN | claimed |
| CN-113004488-A | Stable modified polymer polyol dispersions | 雷普索尔有限公司 | 2021-06-22 | — | — | CN | claimed |
| US-20040115192-A1 | Ligand-targeted emulsions carrying bioactive agents | LANZA GREGORY M (US) | 2004-06-17 | — | — | US | claimed |
| JP-4356417-A | — | — | None | — | — | JP | disclosed |
| WO-2024143430-A1 | SENSOR HAVING VESICLE TEMPLATE | 株式会社TearExo | 2024-07-04 | — | — | WO | disclosed |
| CN-113004488-B | Stable modified polymer polyol dispersions | 雷普索尔有限公司 | 2024-05-07 | — | — | CN | disclosed |
| US-11872313-B2 | Prodrug compositions, prodrug nanoparticles, and methods of use thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-01-16 | — | — | US | disclosed |
| US-11672758-B2 | Endoxifen methods and compositions for inhibition of protein kinase C | JINA PHARMACEUTICALS, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| CN-114903851-A | Capsaicin fat emulsion | 北京泰德制药股份有限公司 | 2022-08-16 | — | — | CN | disclosed |
| US-11141379-B2 | Prodrug compositions, prodrug nanoparticles, and methods of use thereof | WASHINGTON UNIVERSITY (US) | 2021-10-12 | — | — | US | disclosed |
| CN-113004488-A | Stable modified polymer polyol dispersions | 雷普索尔有限公司 | 2021-06-22 | — | — | CN | disclosed |
| WO-2008070463-A2 | ENDOXIFEN METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| EP-1867726-A1 | LIPOSOME CAPABLE OF EFFECTIVE DELIVERY OF GIVEN SUBSTANCE INTO NUCLEUS | National University Corporation Hokkaido University (JP) | 2007-12-19 | — | — | EP | disclosed |
| EP-1847315-A1 | METHOD FOR COATING PARTICLE WITH LIPID FILM | National University Corporation Hokkaido University (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-20070059353-A1 | Polyarginine-modified liposome having nuclear entry ability | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1676588-A1 | POLYARGININE-MODIFIED LIPOSOME CAPABLE OF TRANSFERRING INTO NUCLEUS | Japan Science and Technology Agency (JP) | 2006-07-05 | — | — | EP | disclosed |
| US-20040115192-A1 | Ligand-targeted emulsions carrying bioactive agents | LANZA GREGORY M (US) | 2004-06-17 | — | — | US | disclosed |
| US-6676963-B1 | PROVIDE PROLONGED ASSOCIATION AND INCREASED CONTACT WITH LIPID BILAYER OF SPECIFIED TISSUES OR CELLS | BARNES-JEWISH HOSPITAL | 2004-01-13 | — | — | US | disclosed |
| JP-H04356417-A | FAT EMULSION FOR INTRAVENOUS INJECTION | KAO CORP | 1992-12-10 | — | — | JP | disclosed |
| WO-1992004886-A1 | FAT EMULSION FOR INTRAVENOUS INJECTION | MEITO SANGYO CO., LTD. (JP) | 1992-04-02 | — | — | WO | disclosed |